Jacqueline B. Kosecoff - 31 Dec 2022 Form 5 Insider Report for GoodRx Holdings, Inc. (GDRX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
5
Accepted by SEC
13 Feb 2023, 17:06:31 UTC
Prior SEC filing
05 Aug 2022
Next SEC filing
10 Mar 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gracye Cheng, as Attorney-in-Fact for Jacqueline B. Kosecoff

Key filing fact

Jacqueline B. Kosecoff filed Form 5 for GoodRx Holdings, Inc. (GDRX) on 13 Feb 2023.

Key facts

  • This page summarizes Jacqueline B. Kosecoff's Form 5 filing for GoodRx Holdings, Inc. (GDRX).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Feb 2023, 17:06.

Change

  • Previous filing in this sequence was filed on 05 Aug 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GDRX transaction

Class A Common Stock

Gift

Transaction value
$0
Shares
-6,138
Change %
-18%
Price
$0.000000
Shares after
27,440
Date
17 Aug 2022
Ownership
Direct
Footnotes
F1
GDRX transaction

Class A Common Stock

Gift

Transaction value
$0
Shares
+6,138
Change %
Price
$0.000000
Shares after
6,138
Date
17 Aug 2022
Ownership
By Trust
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On August 17, 2022, the Reporting Person transferred 6,138 shares of Class A common stock to the Robert H. Brook and Jacqueline B. Kosecoff Family Trust, of which the Reporting Person and her spouse serve as trustees and are the sole beneficiaries.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .